share_log

East West Bancorp Analyst Ratings

Benzinga ·  Oct 30, 2023 05:18
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/30/2023 14.02% UBS $57 → $61 Upgrades Neutral → Buy
10/20/2023 6.54% Wedbush $58 → $57 Maintains Neutral
10/03/2023 27.1% Janney Montgomery Scott → $68 Initiates Coverage On → Buy
09/27/2023 15.89% Truist Securities $68 → $62 Maintains Buy
07/24/2023 4.67% Morgan Stanley $56 → $56 Reiterates Equal-Weight → Equal-Weight
07/21/2023 21.5% Wedbush $55 → $65 Maintains Neutral
07/07/2023 4.67% Morgan Stanley $54 → $56 Maintains Equal-Weight
06/29/2023 15.89% Truist Securities $64 → $62 Maintains Buy
05/16/2023 0.93% Morgan Stanley $65 → $54 Maintains Equal-Weight
04/24/2023 8.41% UBS $57 → $58 Maintains Neutral
04/21/2023 15.89% Wedbush $60 → $62 Maintains Neutral
04/21/2023 49.53% Wells Fargo $85 → $80 Maintains Overweight
04/06/2023 51.4% Keefe, Bruyette & Woods $90 → $81 Maintains Outperform
04/05/2023 21.5% Morgan Stanley $88 → $65 Maintains Equal-Weight
03/23/2023 19.63% Truist Securities $85 → $64 Maintains Buy
01/27/2023 58.88% Truist Securities $77 → $85 Maintains Buy
01/27/2023 64.49% Morgan Stanley $84 → $88 Maintains Equal-Weight
12/15/2022 58.88% Wells Fargo $90 → $85 Maintains Overweight
12/05/2022 57.01% Morgan Stanley → $84 Initiates Coverage On → Equal-Weight
10/21/2022 68.22% Wells Fargo $95 → $90 Maintains Overweight
10/06/2022 77.57% Wells Fargo $100 → $95 Maintains Overweight
09/14/2022 62.62% Truist Securities $80 → $87 Maintains Buy
06/30/2022 Wedbush Downgrades Outperform → Neutral
06/13/2022 49.53% Truist Securities $100 → $80 Maintains Buy
04/22/2022 86.92% Wells Fargo $95 → $100 Maintains Overweight
12/06/2021 114.95% Morgan Stanley $100 → $115 Maintains Overweight
10/27/2021 86.92% Morgan Stanley $99 → $100 Maintains Overweight
10/07/2021 77.57% Wells Fargo → $95 Upgrades Equal-Weight → Overweight
09/24/2021 85.05% Morgan Stanley $98 → $99 Maintains Overweight
09/13/2021 68.22% Truist Securities $87 → $90 Maintains Buy
08/11/2021 60.75% Compass Point → $86 Upgrades Neutral → Buy
08/02/2021 83.18% Morgan Stanley $90 → $98 Maintains Overweight
07/23/2021 49.53% Wells Fargo $76 → $80 Maintains Equal-Weight
05/18/2021 53.27% Compass Point $75 → $82 Maintains Neutral
04/29/2021 68.22% Morgan Stanley $85 → $90 Maintains Overweight
03/30/2021 62.62% DA Davidson $62.5 → $87 Upgrades Neutral → Buy
03/18/2021 58.88% Morgan Stanley $79 → $85 Maintains Overweight
03/16/2021 66.36% Jefferies → $89 Initiates Coverage On → Buy
02/24/2021 47.66% Morgan Stanley $73 → $79 Maintains Overweight
02/02/2021 36.45% Morgan Stanley $64 → $73 Maintains Overweight
01/08/2021 32.71% UBS $39 → $71 Upgrades Neutral → Buy
01/07/2021 19.63% Morgan Stanley $59 → $64 Maintains Overweight
12/07/2020 10.28% Morgan Stanley $46 → $59 Maintains Overweight
11/03/2020 -14.02% Morgan Stanley $47 → $46 Maintains Overweight
08/25/2020 -19.63% Truist Securities $40 → $43 Maintains Buy
08/04/2020 -12.15% Morgan Stanley $48 → $47 Maintains Overweight
07/24/2020 -32.71% BMO Capital $34 → $36 Maintains Market Perform
07/07/2020 -38.32% Wells Fargo $31 → $33 Maintains Equal-Weight
06/08/2020 -10.28% Morgan Stanley $45 → $48 Maintains Overweight
05/19/2020 -40.19% SunTrust Robinson Humphrey $31 → $32 Maintains Buy
05/15/2020 -43.93% UBS $24 → $30 Maintains Neutral
05/06/2020 -15.89% Morgan Stanley $43 → $45 Maintains Overweight
04/24/2020 -38.32% DA Davidson $36 → $33 Maintains Neutral
04/07/2020 -19.63% Morgan Stanley $49 → $43 Maintains Overweight
04/06/2020 -55.14% UBS $50 → $24 Maintains Neutral
03/30/2020 -42.06% Wells Fargo $53 → $31 Downgrades Overweight → Equal-Weight
03/17/2020 -8.41% Morgan Stanley $51 → $49 Maintains Overweight
03/05/2020 0.93% Morgan Stanley $60 → $54 Maintains Overweight
01/28/2020 12.15% Morgan Stanley $58 → $60 Maintains Overweight
01/06/2020 -6.54% UBS $58 → $50 Downgrades Buy → Neutral
10/22/2019 0.93% Morgan Stanley $55 → $54 Maintains Overweight
10/18/2019 6.54% Wells Fargo $60 → $57 Maintains Outperform
10/18/2019 -4.67% Wedbush $55 → $51 Maintains Outperform
10/08/2019 Raymond James Downgrades Market Perform → Underperform
10/03/2019 0.93% SunTrust Robinson Humphrey $55 → $54 Maintains Buy
08/29/2019 Raymond James Upgrades Underperform → Market Perform
08/19/2019 -17.76% BMO Capital $51 → $44 Downgrades Outperform → Market Perform
07/08/2019 Raymond James Downgrades Market Perform → Underperform
07/01/2019 6.54% Morgan Stanley $59 → $57 Upgrades Equal-Weight → Overweight
03/08/2019 15.89% Wedbush $59 → $62 Maintains Outperform
12/11/2018 14.02% Morgan Stanley $67 → $61 Maintains Equal-Weight

What is the target price for East West Bancorp (EWBC)?

The latest price target for East West Bancorp (NASDAQ: EWBC) was reported by UBS on October 30, 2023. The analyst firm set a price target for $61.00 expecting EWBC to rise to within 12 months (a possible 14.02% upside). 19 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for East West Bancorp (EWBC)?

The latest analyst rating for East West Bancorp (NASDAQ: EWBC) was provided by UBS, and East West Bancorp upgraded their buy rating.

When is the next analyst rating going to be posted or updated for East West Bancorp (EWBC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of East West Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for East West Bancorp was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.

Is the Analyst Rating East West Bancorp (EWBC) correct?

While ratings are subjective and will change, the latest East West Bancorp (EWBC) rating was a upgraded with a price target of $57.00 to $61.00. The current price East West Bancorp (EWBC) is trading at is $53.50, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment